menu
    • menu

    Company profile for Laurus Labs

    DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

    Virtual Booth

    Contact Supplier

    Valsynthese, part of the SSE Group, is a CDMO focused on highly energetic and highly hazardous chemistry.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    With Fermion, start the journey of your innovative API.

    Virtual Booth

    Contact Supplier

    Bloomage is a one-stop source for CEP Sodium Hyaluronate and Hyaluronic Acid// FDA-inspected & GMP-certified.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    ACTIVE PHARMA INGREDIENTS

    FINISHED DOSAGE FORMULATIONS

    SERVICES

    INSPECTIONS & REGISTRATIONS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Laurus Labs is a leading research and development-driven pharmaceutical company in India. The company has grown consistently to become one of the leading manufacturers of Active Pharmaceutical Ingredients (APIs) for anti-retroviral (ARV) and Hepatitis C. Laurus Labs also manufactures APIs in oncology and other therapeutic areas. Its strategic and early investments in R&D and manufacturing infrastructure have enabled it to beco...
    Laurus Labs is a leading research and development-driven pharmaceutical company in India. The company has grown consistently to become one of the leading manufacturers of Active Pharmaceutical Ingredients (APIs) for anti-retroviral (ARV) and Hepatitis C. Laurus Labs also manufactures APIs in oncology and other therapeutic areas. Its strategic and early investments in R&D and manufacturing infrastructure have enabled it to become one of the leading suppliers of APIs in the ARV therapeutic area. Out of Ten largest generic pharmaceutical companies in the world, by revenues, are our customers.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Laurus Labsindia-flag Flag
    Country
    Country
    India
    Address
    Address
    2nd Floor, Serene Chambers, Rd # 7,Banjara Hills, Hyderabad 500 034
    Telephone
    Telephone
    +91 40 3980 4333
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.lauruslabs.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/laurus-labs/?originalSubdomain=in
    youtube
    YouTube
    Twitter
    Twitter
    https://x.com/lauruslabs?lang=en

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Default Event

    DCAT Week

    Not Confirmed

    envelop Contact Supplier

    DCAT Week

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    INTERVIEW #SpeakPharma

    [Sponsored by another company]
    “Translational Pharmaceutics, our flagship platform for drug development, empowers our clients with unparalleled flexibility”

    “Translational Pharmaceutics, our flagship platform for drug development, empowers our clients with unparalleled flexibility”

    This week, SpeakPharma interviews Denise Sutton, Chief Operating Officer and Site Head at Quotient Sciences’ Nottingham facility in the UK. Quotient Sciences is a drug development and manufacturing accelerator that offers the innovative Translational Pharmaceutics platform to support customers in overcoming drug development challenges. Sutton has been with the company for over 25 years. In this interview, she provides insights into the evolution of Quotient Sciences’ Nottingham facility and discusses how the organization has transformed from a small 10-bed clinic to a comprehensive drug development campus with six GMP suites. She also shares her perspective on the company’s unique approach to integrating drug development services. HIGHLIGHTS// evolution of Quotient Sciences’ Nottingham facility/ unique approach to integrating drug development services How has the Nottingham site transformed from when it was founded, to what it is today? Initially, we were a small company with fewer than 50 employees, a 10-bed clinic, and a single lab. Over 90 percent of our work focused on gamma scintigraphic imaging (a diagnostic test that creates images of the body’s internal organs and tissues using gamma rays). Due to the short half-life radionuclides we used to label dosage forms, every product we manufactured had a limited time to be dosed. At the end of 1999, we moved our headquarters to a purpose-built, two-storey facility—now known as Trent House on our now much larger Nottingham campus. We built three good manufacturing practice (GMP) suites on the top floor and three clinical wards on the bottom floor. These were very early days that marked the start of our Translational Pharmaceutics platform. We continued to expand the range of scintigraphy applications we offered in response to changing customer requirements until, in 2008, when we approached the MHRA (UK’s Medicines and Healthcare products Regulatory Agency) with a new request. We asked if it might be possible to work at the same pace as we did in our scintigraphic imaging studies, but do so for conventional drug development, without the radiolabel. We explored the application of ICH Q8 Quality by Design (QbD) guidelines to introduce a compositional design space into the CMC section of our regulatory dossier. This officially created a methodology for applying the Translational Pharmaceutics platform, and we haven't looked back since. Today, we have expanded substantially. Our Nottingham site is a campus of five buildings. We have development and analytical labs, six GMP suites, six clinical wards with a total of 85 beds (where we conduct healthy volunteer phase 1 clinical studies), and many talented colleagues covering our spectrum of CRO and CDMO services. HIGHLIGHTS// officially created a methodology for applying the Translational Pharmaceutics platform/ development and analytical labs/ six GMP suites   How is Translational Pharmaceutics applied to drug development programs? We apply Translational Pharmaceutics across three core applications: first-in-human clinical studies, drug product optimization programs through rapid formulation development and clinical testing, and as a part of human ADME (absorption, distribution, metabolism, and excretion) programs. No matter how a client chooses to work with us to apply Translational Pharmaceutics, the benefits of using a single organization and project management team to integrate services lets our clients remain in control and one step ahead of the emerging data that impacts the success of their molecule. Over all these years, our flagship Translational Pharmaceutics platform for drug development has remained unchanged in the way it empowers our customers and offers them unparalleled flexibility. HIGHLIGHTS// three core applications/ benefits of using a single organization/ clients remain in control   What would you say are the key strengths of Quotient Sciences’ Nottingham site? How do you support customer programs? Nowhere else would a single project manager oversee such a broad spectrum of activities, let alone be expected to ensure seamless, timely progression across functions that in any other company (i.e. at other CDMOs or CROs) would be delivered through multiple operating areas or through the use of a combination of third-party vendors. The project managers do face challenges. But by working with the project team, they are able to anticipate, avoid, and mitigate any impact whenever necessary. We know that time is incredibly valuable for our customers. A project Gantt chart is our project management team’s guiding light. I believe our project management team is truly world-leading – they communicate well, show great compassion, and lead with integrity. I’m super proud of our high-performing, supportive, cross-functional teams that support our customers when they trust their molecules to us, and work collaboratively to deliver the best possible service. After 25 years at Quotient, I continue to really enjoy going to work. I am indebted to various colleagues for helping me continue to feel this way. HIGHLIGHTS// project management team is truly world-leading/ high-performing, supportive, cross-functional teams/ 25 years at Quotient  

    Impressions: 4520

    subscribeSubscribe

    https://www.pharmacompass.com/speak-pharma/translational-pharmaceutics-our-flagship-platform-for-drug-development-empowers-our-clients-with-unparalleled-flexibility

    Radio Compass
    16 Dec 2024
    Share info Share

    VLOG #PharmaReel

    [Sponsored by another company]

    DATA COMPILATION #PharmaFlow

    [Sponsored by another company]
    CDMO Activity Tracker: Bora, PolPharma make acquisitions; Evonik, EUROAPI, Porton announce technological expansions

    CDMO Activity Tracker: Bora, PolPharma make acquisitions; Evonik, EUROAPI, Porton announce technological expansions

    The contract development and manufacturing organization (CDMO) space continued to grow at an impressive pace in the second half (H2) of 2024, with significant progress being made across cell and gene therapies (CGTs), antibody-drug conjugates (ADCs), novel drug modalities, and digital solutions.Some of the key players in the CDMO space include Lonza, EUROAPI, Evonik, SEQENS, Fujifilm Diosynth Biotechnologies, Quotient Sciences, Axplora, PolPharma, and Famar from Europe; Mission CDMO, LGM Pharma, Veranova, and Thermo Fisher from the US; and Samsung Biologics, Bora Pharmaceuticals, and Porton Pharma Solutions from Asia. Texas-based Mission CDMO has been in the pharma industry for over 75 years. Today, it is known for its comprehensive contract services and high-quality manufacturing capabilities that have reinforced its position as a trusted partner. View CDMO Activity Tracker for H2 2024 (Free Excel Available)Bora, PolPharma drive CDMO acquisitions; Samsung Biologics clocks over US$ 4 bn in contract valueThe second half of 2024 saw several high-value acquisitions and expansions that reshaped the CDMO landscape. South Korea-based Samsung Biologics clocked a cumulative contract value of over US$ 4 billion. It signed its largest manufacturing deal with an Asia-based pharmaceutical company, valued at US$ 1.24 billion. It also announced a series of manufacturing deals with a European drugmaker worth over US$ 668 million. Samsung Biologics is also building a dedicated ADC facility that is likely to be complete soon. Taiwan’s largest CDMO, Bora Pharmaceuticals, announced its second acquisition of the year. It bought New Jersey-based Pyros Pharmaceuticals, a developer of rare disease treatments. Pyros recently launched Vigafyde, the only ready-to-use vigabatrin oral solution and the first new product approved to treat infantile spasms in 15 years. Bora also announced a strategic investment in Tanvex Biopharma, thereby creating a global platform for biologics development and supply.PolPharma acquired Ziołolek, a renowned manufacturer of dermatological products, medical devices, and OTC medicines, thereby expanding its product portfolio. It also launched a state-of-the-art HPAPI (highly potent active pharmaceutical ingredients) facility in Poland, which is being seen as another step towards securing Europe’s drug supply chain.In other developments, Avid Bioservices got acquired by funds managed by Ampersand and British healthcare investment firm GHO Capital Partners in an all-cash deal worth US$ 1.1 billion. And Agilent Technologies agreed to acquire Canadian specialty CDMO Biovectra for US$ 925 million, thereby enhancing its capabilities in gene-editing technologies and sterile fill-finish services. View CDMO Activity Tracker for H2 2024 (Free Excel Available) Evonik, EUROAPI, Porton Pharma, GSK announce tieups, technological expansionsSeveral CDMOs announced new collaborations and acquired new capabilities to enhance their service offerings. Evonik expanded its formulation capabilities for lipid nanoparticles used for mRNA and gene therapies through a collaboration with KNAUER Wissenschaftliche Geräte. This partnership aims to expand Evonik’s portfolio of biosolutions.Evonik is also restructuring its keto and pharma amino acid business to focus on strategic core growth areas. Evonik launched Eudracap colon functional capsules for targeted delivery of oral drugs. These ready-to-fill capsules are designed to release their contents specifically in the colon, improving the efficacy of treatments for various gastrointestinal conditions. Evonik also opened a new facility for drying aqueous dispersions of Eudragit polymers in Darmstadt, Germany. This facility will enhance Evonik’s capabilities in producing high-quality polymers for pharmaceutical applications.EUROAPI launched a new AI-powered Electronic Batch Record solution in collaboration with Aizon to enhance manufacturing productivity. This collaboration aims to digitize operations towards more data-driven manufacturing, focusing on small-scale productions and highly flexible plants.Porton Pharma Solutions has expanded its reach through several strategic initiatives. In October, Porton entered into a partnership with Shanghai InnoStar to enhance its service offerings beyond small molecules, targeting peptides, oligonucleotide drugs, conjugated drugs, and advanced therapies. It continued to grow its capabilities by enhancing its GMP manufacturing capacity in Fengxian, Shanghai (China). The facility’s expansion is aimed at increasing the production of novel therapies, including peptides and oligonucleotide drugs. These moves are part of Porton’s broader strategy to position itself at the forefront of advanced pharmaceutical manufacturing.Corden Pharma is investing € 900 million (US$ 985 million) over the next three years to expand its peptide platform facilities in Colorado (US) and Europe. While the US site will help meet the rising demand for GLP-1 peptides, in Europe, CordenPharma will construct a greenfield facility for small to large-scale peptide development and manufacturing.CDMO Touchlight signed a licensing agreement with GSK that grants the drug behemoth non-exclusive rights to use Touchlight’s proprietary enzymatic doggybone DNA (dbDNA) technology for the development and production of mRNA-based products, particularly vaccines. Curia also integrated enzymatic dbDNA solutions through a collaboration with Touchlight, enhancing mRNA production for vaccine and cancer therapies. View CDMO Activity Tracker for H2 2024 (Free Excel Available) Lonza, Merck, Dr. Reddy’s owned Aurigene invest in cell and gene therapiesThe CGT space continued to draw both deals and investments. Lonza and Vertex signed a long-term commercial supply agreement for Casgevy, the world’s first CRISPR/Cas9 gene-edited cell therapy, to treat sickle cell disease and beta thalassemia. This agreement includes manufacturing at Lonza’s Geleen (the Netherlands) cell therapy manufacturing facility, with plans to expand to Portsmouth, New Hampshire (US).Miltenyi Biotec began manufacturing lentiviral vectors for Adaptimmune’s Tecelra, the first engineered TCR T-cell therapy for the rare soft tissue cancer synovial sarcoma approved by the US Food and Drug Administration.Merck KGaA commenced commercial production at its first GMP-compliant manufacturing line for cell culture media (CCM) in China. This facility addresses the growing local demand for quality custom CCM used in biopharmaceuticals, vaccines, and novel therapeutics.Aurigene and Edity Therapeutics announced a strategic collaboration in cell therapy, with Aurigene providing cell therapy discovery services to support Edity’s clinical development. Additionally, Aurigene and its parent, Dr. Reddy’s Laboratories, signed a memorandum of understanding (MoU) with Kainomyx for the development and commercialization of an affordable anti-malarial drug. ProBio and UCI Therapeutics signed an MoU for a comprehensive collaboration in gene delivery technologies, including viral and non-viral approaches. Additionally, Korea’s VaxCell-Bio partnered with ProBio to accelerate the development of its chimeric antigen receptor (CAR)-related therapies.The ADC market continued to be a hotbed of innovation and strategic expansion. Merck KGaA invested € 70 million (US$ 75 million) to triple its ADC manufacturing capacity at its Missouri (US) facility, aiming to support the rising demand for oncology therapies.Sterling Pharma entered into a partnership with GlycoNex to support the clinical trials of their ADCs that target solid tumors. And, NJ Bio and Charles River Laboratories also announced a collaboration to optimize ADC manufacturing.The adeno-associated viral (AAV) vector field also saw activity with Rentschler Biopharma and Forge Biologics announcing the launch of a new service offering and a manufacturing platform, respectively. Similarly, Andelyn Biosciences was selected by Hubble Therapeutics to manufacture clinical grade AAV.Meanwhile, Lonza has gone in for a restructuring exercise in order to become a “pure-play CDMO”. It has exited its capsules and health ingredients business, and adopted a new organizational structure. The Swiss CDMO has also extended a collaboration with a major global biopharmaceutical partner for commercial-scale manufacture of ADCs. View CDMO Activity Tracker for H2 2024 (Free Excel Available) Our viewAs pharmaceutical development becomes increasingly complex, CDMOs are no longer just manufacturing partners, but critical innovation hubs. Little wonder then that 2024’s biggest pharma deal was in the CDMO space – Novo Holdings’ US$ 16.5 billion buyout of Catalent. This trend should gather momentum. We expect more M&A activity in this space in 2025. 
    subscribeSubscribe
    ExcelExcel Download

    Impressions: 222

    https://www.pharmacompass.com/radio-compass-blog/cdmo-activity-tracker-bora-polpharma-make-acquisitions-evonik-euroapi-porton-announce-technological-expansions

    #PharmaFlow by PHARMACOMPASS
    19 Dec 2024
    Share Share

    NEWS #PharmaBuzz

    read-more
    read-more
    Laurus Labs invests in Laurus Bio
    Laurus Labs invests in Laurus Bio

    09 Dec 2024

    // INDPHARMAPOST

    https://www.indianpharmapost.com/news/laurus-labs-invests-in-laurus-bio-16516

    INDPHARMAPOST
    09 Dec 2024
    Share Share
    Laurus Labs posts Financial Results Q2 FY 2025
    Laurus Labs posts Financial Results Q2 FY 2025

    24 Oct 2024

    // PRESS RELEASE

    https://www.lauruslabs.com/Investors/PDF/PressReleases/PressRelease16092024.pdf

    PRESS RELEASE
    24 Oct 2024
    Share Share
    Laurus Labs inaugurates new R&D facility at IKP Knowledge Park
    Laurus Labs inaugurates new R&D facility at IKP Knowledge Park

    19 Sep 2024

    // PRESS RELEASE

    https://www.lauruslabs.com/Investors/PDF/PressReleases/PressRelease16092024.pdf

    PRESS RELEASE
    19 Sep 2024
    Share Share
    Laurus Labs opens new R&D facility in IKP Knowledge Park, Hyderabad
    Laurus Labs opens new R&D facility in IKP Knowledge Park, Hyderabad

    16 Sep 2024

    // ECONOMICTIMES

    https://economictimes.indiatimes.com/industry/healthcare/biotech/laurus-labs-opens-new-rd-facility-in-ikp-knowledge-park-hyderabad/articleshow/113391501.cms

    ECONOMICTIMES
    16 Sep 2024
    Share Share
    Laurus Labs API Facility Passes USFDA Audit With Zero Observations
    Laurus Labs API Facility Passes USFDA Audit With Zero Observations

    14 Sep 2024

    // INDPHARMAPOST

    https://www.indianpharmapost.com/drug-approval/usfda-concludes-audit-for-laurus-labs-api-manufacturing-facility-at-hyderabad-with-zero-form-483-observations-16178

    INDPHARMAPOST
    14 Sep 2024
    Share Share
    Laurus Labs Q1 FY25: ?1,195 Cr Revenue, ?171 Cr EBITDA
    Laurus Labs Q1 FY25: ?1,195 Cr Revenue, ?171 Cr EBITDA

    25 Jul 2024

    // PRESS RELEASE

    https://www.lauruslabs.com/Investors/PDF/PressReleases/PressnoteLaurusLabsAnnouncesQ1FY25ResultsRevenues260724.pdf

    PRESS RELEASE
    25 Jul 2024
    Share Share

    ALL APIs

    read-moreClick the button for full data set
    read-moreClick the button for full data set

    01

    Gemcitabine

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    Antibody Engineering
    Not Confirmed
    arrow

    Gemcitabine

    India

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    arrow
    Antibody Engineering
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    USDMF arrow-down Click Us! arrow-down
    ✖

    GDUFA

    DMF Review : Reviewed

    Rev. Date : 2012-11-23

    Pay. Date : 2012-11-16

    DMF Number : 22800

    Submission : 2009-05-16

    Status : Active

    Type : II

     CEP/COS arrow-down
    ✖

    Certificate Number : R1-CEP 2009-026 - Rev 02

    Issue Date : 2023-01-24

    Type : Chemical

    Substance Number : 2306

    Status : Valid

     JDMF arrow-down
    ✖

    Registration Number : 230MF10069

    Registrant's Address : 2nd Floor, Serene Chambers, Road No#7, Banjara Hills, Hyderabad, Telangana, INDIA

    Initial Date of Registration : 2018-06-05

    Latest Date of Registration :

    EU-WCarrow-down
    ✖

    Date of Issue : 2023-07-03

    Valid Till : 2025-07-02

    Written Confirmation Number : WC-0213

    Address of the Firm :

    NDC arrow-down
    ✖

    NDC Package Code : 42385-748

    Start Marketing Date : 2009-05-16

    End Marketing Date : 2024-12-31

    Dosage Form (Strength) : POWDER (1kg/kg)

    Marketing Category : BULK INGREDIENT

    KDMF arrow-down
    ✖

    Registrant Name : Samyang Holdings Co., Ltd.

    Registration Date : 2021-07-13

    Registration Number : 20110516-86-D-100-15(6)

    Manufacturer Name : Laurus Labs Limited

    Manufacturer Address : Plot No. 21, Jawaharlal Nehru Pharma City Parawada, Anakapalli-531 021,Andhra Pradesh, India

     VMF Others AUDIT
    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    02

    Metformin

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    Antibody Engineering
    Not Confirmed
    arrow

    Metformin

    India

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    arrow
    Antibody Engineering
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    USDMF arrow-down
    ✖

    GDUFA

    DMF Review : Reviewed

    Rev. Date : 2016-06-14

    Pay. Date : 2016-04-04

    DMF Number : 30114

    Submission : 2016-05-04

    Status : Active

    Type : II

     CEP/COS arrow-down
    ✖

    Certificate Number : R1-CEP 2016-319 - Rev 01

    Issue Date : 2023-01-24

    Type : Chemical

    Substance Number : 931

    Status : Valid

     JDMF arrow-down
    ✖

    Registration Number : 306MF10025

    Registrant's Address : 2nd Floor, Serene Chambers, Road No:7, Banjara Hills, Hyderabad - 500034, Telangana, India

    Initial Date of Registration : 2024-02-07

    Latest Date of Registration :

    EU-WCarrow-down
    ✖

    Date of Issue : 2023-07-03

    Valid Till : 2025-07-02

    Written Confirmation Number : WC-0213

    Address of the Firm :

    NDC arrow-down
    ✖

    NDC Package Code : 42385-501

    Start Marketing Date : 2016-04-19

    End Marketing Date : 2024-12-31

    Dosage Form (Strength) : POWDER (1kg/kg)

    Marketing Category : BULK INGREDIENT

    KDMF arrow-down
    ✖

    Registrant Name : Sangjin Corporation

    Registration Date : 2024-04-16

    Registration Number : 20240416-37-C-410-30

    Manufacturer Name : Laurus Labs Limited

    Manufacturer Address : Unit-II, Plot No. 19, 20 & 21, Western Sector, APSEZ, Atchutapuram Mandal, Visakhapatnam District- 531 011, Andhra Pradesh, India

     VMF Others AUDIT
    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    03

    Abacavir Sulfate

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    Antibody Engineering
    Not Confirmed
    arrow

    Abacavir Sulfate

    India

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    arrow
    Antibody Engineering
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    USDMF arrow-down
    ✖

    GDUFA

    DMF Review : Reviewed

    Rev. Date : 2015-05-20

    Pay. Date : 2014-11-21

    DMF Number : 28818

    Submission : 2014-12-15

    Status : Active

    Type : II

     CEP/COS arrow-down
    ✖

    Certificate Number : R1-CEP 2014-353 - Rev 01

    Issue Date : 2023-02-15

    Type : Chemical

    Substance Number : 2589

    Status : Valid

     JDMF EU-WCarrow-down
    ✖

    Date of Issue : 2023-07-03

    Valid Till : 2025-07-02

    Written Confirmation Number : WC-0213

    Address of the Firm :

    NDC KDMF VMF Others AUDIT
    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    04

    Bortezomib

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    Antibody Engineering
    Not Confirmed
    arrow

    Bortezomib

    India

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    arrow
    Antibody Engineering
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    USDMF arrow-down
    ✖

    GDUFA

    DMF Review : Reviewed

    Rev. Date : 2013-09-06

    Pay. Date : 2012-12-18

    DMF Number : 26774

    Submission : 2012-12-19

    Status : Active

    Type : II

     CEP/COS JDMF arrow-down
    ✖

    Registration Number : 228MF10207

    Registrant's Address : 2nd Floor, Serene Chambers, Road No#7, Banjara Hills, Hyderabad, Telangana, INDIA

    Initial Date of Registration : 2016-11-02

    Latest Date of Registration :

    EU-WCarrow-down
    ✖

    Date of Issue : 2023-07-03

    Valid Till : 2025-07-02

    Written Confirmation Number : WC-0213

    Address of the Firm :

    NDC arrow-down
    ✖

    NDC Package Code : 42385-716

    Start Marketing Date : 2012-12-18

    End Marketing Date : 2024-12-31

    Dosage Form (Strength) : POWDER (1g/g)

    Marketing Category : BULK INGREDIENT

    KDMF arrow-down
    ✖

    Registrant Name : Pharma Science Korea Co., Ltd.

    Registration Date : 2022-02-04

    Registration Number : No.87-25-ND(1)

    Manufacturer Name : Laurus Labs Limited(Unit-1)

    Manufacturer Address : Plot No. 21, Jawaharlal Nehru Pharma City,Parawada(M), Visakhapatnam-531021,Andhra Pradesh,India

     VMF Others AUDIT
    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    05

    Hydroxychloroquine Sulphate

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    Antibody Engineering
    Not Confirmed
    arrow

    Hydroxychloroquine Sulphate

    India

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    arrow
    Antibody Engineering
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    USDMF arrow-down
    ✖

    GDUFA

    DMF Review : Reviewed

    Rev. Date : 2017-10-19

    Pay. Date : 2017-08-30

    DMF Number : 31956

    Submission : 2017-09-08

    Status : Active

    Type : II

     CEP/COS arrow-down
    ✖

    Certificate Number : R0-CEP 2020-129 - Rev 02

    Issue Date : 2023-01-25

    Type : Chemical

    Substance Number : 2849

    Status : Valid

     JDMF EU-WCarrow-down
    ✖

    Date of Issue : 2023-07-03

    Valid Till : 2025-07-02

    Written Confirmation Number : WC-0213

    Address of the Firm :

    NDC KDMF VMF Others AUDIT
    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    06

    Imatinib Mesylate

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    Antibody Engineering
    Not Confirmed
    arrow

    Imatinib Mesylate

    India

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    arrow
    Antibody Engineering
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    USDMF arrow-down
    ✖

    GDUFA

    DMF Review : Reviewed

    Rev. Date : 2013-06-20

    Pay. Date : 2013-05-13

    DMF Number : 27089

    Submission : 2013-05-09

    Status : Active

    Type : II

     CEP/COS arrow-down
    ✖

    Certificate Number : R1-CEP 2015-245 - Rev 01

    Issue Date : 2023-01-18

    Type : Chemical

    Substance Number : 2736

    Status : Valid

     JDMF EU-WCarrow-down
    ✖

    Date of Issue : 2023-07-03

    Valid Till : 2025-07-02

    Written Confirmation Number : WC-0213

    Address of the Firm :

    NDC arrow-down
    ✖

    NDC Package Code : 42385-316

    Start Marketing Date : 2013-05-09

    End Marketing Date : 2024-12-31

    Dosage Form (Strength) : POWDER (1kg/kg)

    Marketing Category : BULK INGREDIENT

    KDMF VMF Others AUDIT
    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    07

    Irinotecan Hydrochloride

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    Antibody Engineering
    Not Confirmed
    arrow

    Irinotecan Hydrochloride

    India

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    arrow
    Antibody Engineering
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    USDMF arrow-down
    ✖

    GDUFA

    DMF Review : Reviewed

    Rev. Date : 2018-11-02

    Pay. Date : 2018-10-31

    DMF Number : 22296

    Submission : 2008-11-21

    Status : Active

    Type : II

     CEP/COS arrow-down
    ✖

    Certificate Number : CEP 2019-292 - Rev 02

    Issue Date : 2023-12-11

    Type : Chemical

    Substance Number : 2675

    Status : Valid

     JDMF EU-WCarrow-down
    ✖

    Date of Issue : 2023-07-03

    Valid Till : 2025-07-02

    Written Confirmation Number : WC-0213

    Address of the Firm :

    NDC arrow-down
    ✖

    NDC Package Code : 42385-711

    Start Marketing Date : 2008-11-21

    End Marketing Date : 2024-12-31

    Dosage Form (Strength) : POWDER (1kg/kg)

    Marketing Category : BULK INGREDIENT

    KDMF arrow-down
    ✖

    Registrant Name : Iksoo Pharmaceutical Co., Ltd.

    Registration Date : 2021-03-16

    Registration Number : 20210316-210-J-880

    Manufacturer Name : Laurus Labs Private Limited

    Manufacturer Address : Plot No. 21, Jawaharlal Nehru Pharma City, Parawada, Anakapalli-531021, Andhra Pradesh, India

     VMF Others AUDIT
    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    08

    Lamivudine

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    Antibody Engineering
    Not Confirmed
    arrow

    Lamivudine

    India

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    arrow
    Antibody Engineering
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    USDMF arrow-down
    ✖

    GDUFA

    DMF Review : Reviewed

    Rev. Date : 2017-08-04

    Pay. Date : 2017-06-28

    DMF Number : 31854

    Submission : 2017-07-07

    Status : Active

    Type : II

     CEP/COS arrow-down
    ✖

    Certificate Number : R1-CEP 2016-045 - Rev 01

    Issue Date : 2023-01-24

    Type : Chemical

    Substance Number : 2217

    Status : Valid

     JDMF EU-WCarrow-down
    ✖

    Date of Issue : 2023-07-03

    Valid Till : 2025-07-02

    Written Confirmation Number : WC-0213

    Address of the Firm :

    NDC arrow-down
    ✖

    NDC Package Code : 42385-714

    Start Marketing Date : 2017-07-07

    End Marketing Date : 2024-12-31

    Dosage Form (Strength) : POWDER (1kg/kg)

    Marketing Category : BULK INGREDIENT

    KDMF arrow-down
    ✖

    Registrant Name : Korea MSD Co., Ltd.

    Registration Date : 2022-01-10

    Registration Number : 20220110-209-J-1202

    Manufacturer Name : Laurus Labs Limited (Unit 1)

    Manufacturer Address : Plot No.21, Jawaharlal Nehru Pharma City, Parawada, Anakapalli-531021, Andhra Pradesh, India

     VMF Others AUDIT
    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    09

    Montelukast Sodium

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    Antibody Engineering
    Not Confirmed
    arrow

    Montelukast Sodium

    India

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    arrow
    Antibody Engineering
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    USDMF arrow-down
    ✖

    GDUFA

    DMF Review : Reviewed

    Rev. Date : 2017-03-24

    Pay. Date : 2017-03-13

    DMF Number : 23736

    Submission : 2010-04-16

    Status : Active

    Type : II

     CEP/COS arrow-down
    ✖

    Certificate Number : CEP 2013-311 - Rev 02

    Issue Date : 2024-11-25

    Type : Chemical

    Substance Number : 2583

    Status : Valid

     JDMF EU-WCarrow-down
    ✖

    Date of Issue : 2023-07-03

    Valid Till : 2025-07-02

    Written Confirmation Number : WC-0213

    Address of the Firm :

    NDC arrow-down
    ✖

    NDC Package Code : 42385-709

    Start Marketing Date : 2010-04-16

    End Marketing Date : 2024-12-31

    Dosage Form (Strength) : POWDER (1kg/kg)

    Marketing Category : BULK INGREDIENT

    KDMF arrow-down
    ✖

    Registrant Name : Hanyoung Farm Co., Ltd.

    Registration Date : 2022-07-06

    Registration Number : 20190426-209-J-170(1)

    Manufacturer Name : Laurus Labs Limited

    Manufacturer Address : Plot No.21, Jawaharlal Nehru Pharma City, Parawada, Visakhapatnam-531021, Andhra Pradesh, India

     VMF Others AUDIT
    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    10

    Pregabalin

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    Antibody Engineering
    Not Confirmed
    arrow

    Pregabalin

    India

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    arrow
    Antibody Engineering
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    USDMF arrow-down
    ✖

    GDUFA

    DMF Review : Reviewed

    Rev. Date : 2017-05-17

    Pay. Date : 2017-04-17

    DMF Number : 31415

    Submission : 2017-05-06

    Status : Active

    Type : II

     CEP/COS arrow-down
    ✖

    Certificate Number : CEP 2017-266 - Rev 03

    Issue Date : 2024-07-03

    Type : Chemical

    Substance Number : 2777

    Status : Valid

     JDMF EU-WCarrow-down
    ✖

    Date of Issue : 2023-07-03

    Valid Till : 2025-07-02

    Written Confirmation Number : WC-0213

    Address of the Firm :

    NDC arrow-down
    ✖

    NDC Package Code : 42385-308

    Start Marketing Date : 2019-08-06

    End Marketing Date : 2024-12-31

    Dosage Form (Strength) : POWDER (1kg/kg)

    Marketing Category : BULK INGREDIENT

    KDMF VMF Others AUDIT
    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    Only 10 entries up to this point, click to access all click full view read-more
    click full view
    Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

    FDF Dossiers

    read-more
    read-more

    01

    Brand Name : ABACAVIR SULFATE AND...

    India
    Antibody Engineering
    Not Confirmed
    arrow

    Brand Name : ABACAVIR SULFATE AND...

    India
    arrow
    Antibody Engineering
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Regulatory Info : RX

    Registration Country : USA

    ABACAVIR SULFATE; LAMIVUDINE

    Laurus Labs

    Dosage Form : TABLET;ORAL

    Brand Name : ABACAVIR SULFATE AND LAMI...

    Dosage Strength : EQ 600MG BASE;300MG

    Packaging :

    Approval Date : 2022-07-25

    Application Number : 216332

    Regulatory Info : RX

    Registration Country : USA

    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    02

    Brand Name : ABACAVIR; DOLUTEGRAV...

    India
    Antibody Engineering
    Not Confirmed
    arrow

    Brand Name : ABACAVIR; DOLUTEGRAV...

    India
    arrow
    Antibody Engineering
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Regulatory Info :

    Registration Country : USA

    Abacavir; Dolutegravir; Lamivudine

    Laurus Labs

    Dosage Form : TABLET;ORAL

    Brand Name : ABACAVIR; DOLUTEGRAVIR; L...

    Dosage Strength : 600MG;50MG;300MG

    Packaging :

    Approval Date :

    Application Number : 216223

    Regulatory Info :

    Registration Country : USA

    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    03

    Brand Name : ATAZANAVIR SULFATE

    India
    Antibody Engineering
    Not Confirmed
    arrow

    Brand Name : ATAZANAVIR SULFATE

    India
    arrow
    Antibody Engineering
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Regulatory Info : RX

    Registration Country : USA

    ATAZANAVIR SULFATE

    Laurus Labs

    Dosage Form : CAPSULE;ORAL

    Brand Name : ATAZANAVIR SULFATE

    Dosage Strength : EQ 150MG BASE

    Packaging :

    Approval Date : 2021-04-30

    Application Number : 212579

    Regulatory Info : RX

    Registration Country : USA

    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    04

    Brand Name : ATAZANAVIR SULFATE

    India
    Antibody Engineering
    Not Confirmed
    arrow

    Brand Name : ATAZANAVIR SULFATE

    India
    arrow
    Antibody Engineering
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Regulatory Info : RX

    Registration Country : USA

    ATAZANAVIR SULFATE

    Laurus Labs

    Dosage Form : CAPSULE;ORAL

    Brand Name : ATAZANAVIR SULFATE

    Dosage Strength : EQ 300MG BASE

    Packaging :

    Approval Date : 2021-04-30

    Application Number : 212579

    Regulatory Info : RX

    Registration Country : USA

    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    05

    Brand Name : ATAZANAVIR SULFATE

    India
    Antibody Engineering
    Not Confirmed
    arrow

    Brand Name : ATAZANAVIR SULFATE

    India
    arrow
    Antibody Engineering
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Regulatory Info : RX

    Registration Country : USA

    ATAZANAVIR SULFATE

    Laurus Labs

    Dosage Form : CAPSULE;ORAL

    Brand Name : ATAZANAVIR SULFATE

    Dosage Strength : EQ 200MG BASE

    Packaging :

    Approval Date : 2021-04-30

    Application Number : 212579

    Regulatory Info : RX

    Registration Country : USA

    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    06

    Brand Name : ATORVASTATIN CALCIUM

    India
    Antibody Engineering
    Not Confirmed
    arrow

    Brand Name : ATORVASTATIN CALCIUM

    India
    arrow
    Antibody Engineering
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Regulatory Info : RX

    Registration Country : USA

    ATORVASTATIN CALCIUM

    Laurus Labs

    Dosage Form : TABLET;ORAL

    Brand Name : ATORVASTATIN CALCIUM

    Dosage Strength : EQ 10MG BASE

    Packaging :

    Approval Date : 2024-01-22

    Application Number : 214513

    Regulatory Info : RX

    Registration Country : USA

    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    07

    Brand Name : ATORVASTATIN CALCIUM

    India
    Antibody Engineering
    Not Confirmed
    arrow

    Brand Name : ATORVASTATIN CALCIUM

    India
    arrow
    Antibody Engineering
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Regulatory Info : RX

    Registration Country : USA

    ATORVASTATIN CALCIUM

    Laurus Labs

    Dosage Form : TABLET;ORAL

    Brand Name : ATORVASTATIN CALCIUM

    Dosage Strength : EQ 40MG BASE

    Packaging :

    Approval Date : 2024-01-22

    Application Number : 214513

    Regulatory Info : RX

    Registration Country : USA

    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    08

    Brand Name : ATORVASTATIN CALCIUM

    India
    Antibody Engineering
    Not Confirmed
    arrow

    Brand Name : ATORVASTATIN CALCIUM

    India
    arrow
    Antibody Engineering
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Regulatory Info : RX

    Registration Country : USA

    ATORVASTATIN CALCIUM

    Laurus Labs

    Dosage Form : TABLET;ORAL

    Brand Name : ATORVASTATIN CALCIUM

    Dosage Strength : EQ 20MG BASE

    Packaging :

    Approval Date : 2024-01-22

    Application Number : 214513

    Regulatory Info : RX

    Registration Country : USA

    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    09

    Brand Name : ATORVASTATIN CALCIUM

    India
    Antibody Engineering
    Not Confirmed
    arrow

    Brand Name : ATORVASTATIN CALCIUM

    India
    arrow
    Antibody Engineering
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Regulatory Info : RX

    Registration Country : USA

    ATORVASTATIN CALCIUM

    Laurus Labs

    Dosage Form : TABLET;ORAL

    Brand Name : ATORVASTATIN CALCIUM

    Dosage Strength : EQ 80MG BASE

    Packaging :

    Approval Date : 2024-01-22

    Application Number : 214513

    Regulatory Info : RX

    Registration Country : USA

    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    10

    Brand Name : CANAGLIFLOZIN

    India
    Antibody Engineering
    Not Confirmed
    arrow

    Brand Name : CANAGLIFLOZIN

    India
    arrow
    Antibody Engineering
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Regulatory Info :

    Registration Country : USA

    CANAGLIFLOZIN

    Laurus Labs

    Dosage Form : TABLET;ORAL

    Brand Name : CANAGLIFLOZIN

    Dosage Strength : 300MG

    Packaging :

    Approval Date :

    Application Number : 210503

    Regulatory Info :

    Registration Country : USA

    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    Only 10 entries up to this point, click to access all click full view read-more
    click full view
    Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

    FDA Orange Book

    read-more
    read-more

    01

    Brand Name : ABACAVIR SULFATE AND...

    India
    Antibody Engineering
    Not Confirmed
    arrow

    Brand Name : ABACAVIR SULFATE AND...

    India
    Antibody Engineering
    Not Confirmed
    arrow
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    RLD : No

    TE Code : AB

    ABACAVIR SULFATE; LAMIVUDINE

    Laurus Labs

    Dosage Form : TABLET; ORAL

    Proprietary Name : ABACAVIR SULFATE AND LAM...

    Dosage Strength : EQ 600MG BASE;300MG

    Approval Date : 2022-07-25

    Application Number : 216332

    RX/OTC/DISCN : RX

    RLD : No

    TE Code : AB

    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    02

    Brand Name : ABACAVIR; DOLUTEGRAV...

    India
    Antibody Engineering
    Not Confirmed
    arrow

    Brand Name : ABACAVIR; DOLUTEGRAV...

    India
    Antibody Engineering
    Not Confirmed
    arrow
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    RLD :

    TE Code :

    ABACAVIR; DOLUTEGRAVIR; LAMIVUDINE

    Laurus Labs

    Dosage Form : TABLET; ORAL

    Proprietary Name : ABACAVIR; DOLUTEGRAVIR; ...

    Dosage Strength : 600MG;50MG;300MG

    Approval Date :

    Application Number : 216223

    RX/OTC/DISCN :

    RLD :

    TE Code :

    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    03

    Brand Name : ATAZANAVIR SULFATE

    India
    Antibody Engineering
    Not Confirmed
    arrow

    Brand Name : ATAZANAVIR SULFATE

    India
    Antibody Engineering
    Not Confirmed
    arrow
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    RLD : No

    TE Code : AB

    ATAZANAVIR SULFATE

    Laurus Labs

    Dosage Form : CAPSULE; ORAL

    Proprietary Name : ATAZANAVIR SULFATE

    Dosage Strength : EQ 150MG BASE

    Approval Date : 2021-04-30

    Application Number : 212579

    RX/OTC/DISCN : RX

    RLD : No

    TE Code : AB

    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    04

    Brand Name : ATAZANAVIR SULFATE

    India
    Antibody Engineering
    Not Confirmed
    arrow

    Brand Name : ATAZANAVIR SULFATE

    India
    Antibody Engineering
    Not Confirmed
    arrow
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    RLD : No

    TE Code : AB

    ATAZANAVIR SULFATE

    Laurus Labs

    Dosage Form : CAPSULE; ORAL

    Proprietary Name : ATAZANAVIR SULFATE

    Dosage Strength : EQ 200MG BASE

    Approval Date : 2021-04-30

    Application Number : 212579

    RX/OTC/DISCN : RX

    RLD : No

    TE Code : AB

    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    05

    Brand Name : ATAZANAVIR SULFATE

    India
    Antibody Engineering
    Not Confirmed
    arrow

    Brand Name : ATAZANAVIR SULFATE

    India
    Antibody Engineering
    Not Confirmed
    arrow
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    RLD : No

    TE Code : AB

    ATAZANAVIR SULFATE

    Laurus Labs

    Dosage Form : CAPSULE; ORAL

    Proprietary Name : ATAZANAVIR SULFATE

    Dosage Strength : EQ 300MG BASE

    Approval Date : 2021-04-30

    Application Number : 212579

    RX/OTC/DISCN : RX

    RLD : No

    TE Code : AB

    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    06

    Brand Name : ATORVASTATIN CALCIUM

    India
    Antibody Engineering
    Not Confirmed
    arrow

    Brand Name : ATORVASTATIN CALCIUM

    India
    Antibody Engineering
    Not Confirmed
    arrow
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    RLD : No

    TE Code : AB

    ATORVASTATIN CALCIUM

    Laurus Labs

    Dosage Form : TABLET; ORAL

    Proprietary Name : ATORVASTATIN CALCIUM

    Dosage Strength : EQ 10MG BASE

    Approval Date : 2024-01-22

    Application Number : 214513

    RX/OTC/DISCN : RX

    RLD : No

    TE Code : AB

    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    07

    Brand Name : ATORVASTATIN CALCIUM

    India
    Antibody Engineering
    Not Confirmed
    arrow

    Brand Name : ATORVASTATIN CALCIUM

    India
    Antibody Engineering
    Not Confirmed
    arrow
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    RLD : No

    TE Code : AB

    ATORVASTATIN CALCIUM

    Laurus Labs

    Dosage Form : TABLET; ORAL

    Proprietary Name : ATORVASTATIN CALCIUM

    Dosage Strength : EQ 20MG BASE

    Approval Date : 2024-01-22

    Application Number : 214513

    RX/OTC/DISCN : RX

    RLD : No

    TE Code : AB

    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    08

    Brand Name : ATORVASTATIN CALCIUM

    India
    Antibody Engineering
    Not Confirmed
    arrow

    Brand Name : ATORVASTATIN CALCIUM

    India
    Antibody Engineering
    Not Confirmed
    arrow
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    RLD : No

    TE Code : AB

    ATORVASTATIN CALCIUM

    Laurus Labs

    Dosage Form : TABLET; ORAL

    Proprietary Name : ATORVASTATIN CALCIUM

    Dosage Strength : EQ 40MG BASE

    Approval Date : 2024-01-22

    Application Number : 214513

    RX/OTC/DISCN : RX

    RLD : No

    TE Code : AB

    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    09

    Brand Name : ATORVASTATIN CALCIUM

    India
    Antibody Engineering
    Not Confirmed
    arrow

    Brand Name : ATORVASTATIN CALCIUM

    India
    Antibody Engineering
    Not Confirmed
    arrow
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    RLD : No

    TE Code : AB

    ATORVASTATIN CALCIUM

    Laurus Labs

    Dosage Form : TABLET; ORAL

    Proprietary Name : ATORVASTATIN CALCIUM

    Dosage Strength : EQ 80MG BASE

    Approval Date : 2024-01-22

    Application Number : 214513

    RX/OTC/DISCN : RX

    RLD : No

    TE Code : AB

    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    10

    Brand Name : CANAGLIFLOZIN

    India
    Antibody Engineering
    Not Confirmed
    arrow

    Brand Name : CANAGLIFLOZIN

    India
    Antibody Engineering
    Not Confirmed
    arrow
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    RLD :

    TE Code :

    CANAGLIFLOZIN

    Laurus Labs

    Dosage Form : TABLET; ORAL

    Proprietary Name : CANAGLIFLOZIN

    Dosage Strength : 300MG

    Approval Date :

    Application Number : 210503

    RX/OTC/DISCN :

    RLD :

    TE Code :

    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    Only 10 entries up to this point, click to access all click full view read-more
    click full view

    Services

    Upload your portfolio for free, ask us

    API & Drug Product Development

    Click here to discover the service providers for API & Drug Product Development

    API Development

    read-more
    read-more

    01

    STEROIDAL HORMONE API DEVELOPMEN...

    STEROIDAL HORMONE API DEVELOPMENT

    arrow
    Antibody Engineering
    Not Confirmed
    Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

    Inspections and registrations

    Upload your audits for free, ask us

    Others

    read-more
    read-more

    ABOUT THIS PAGE

    Contact Laurus Labs and get a quotation

    Laurus Labs is a supplier offers 122 products (APIs, Excipients or Intermediates).

    Find a price of Gemcitabine bulk with DMF, CEP, JDMF, WC offered by Laurus Labs

    Find a price of Metformin bulk with DMF, CEP, JDMF, WC offered by Laurus Labs

    Find a price of Abacavir Sulfate bulk with DMF, CEP, WC offered by Laurus Labs

    Find a price of Bortezomib bulk with DMF, JDMF, WC offered by Laurus Labs

    Find a price of Hydroxychloroquine Sulphate bulk with DMF, CEP, WC offered by Laurus Labs

    Find a price of Imatinib Mesylate bulk with DMF, CEP, WC offered by Laurus Labs

    Find a price of Irinotecan Hydrochloride bulk with DMF, CEP, WC offered by Laurus Labs

    Find a price of Lamivudine bulk with DMF, CEP, WC offered by Laurus Labs

    Find a price of Montelukast Sodium bulk with DMF, CEP, WC offered by Laurus Labs

    Find a price of Oseltamivir Phosphate bulk with DMF, CEP, WC offered by Laurus Labs

    Find a price of Pregabalin bulk with DMF, CEP, WC offered by Laurus Labs

    Find a price of Ritonavir bulk with DMF, CEP, WC offered by Laurus Labs

    Find a price of Carboplatin bulk with DMF, CEP offered by Laurus Labs

    Find a price of Cisplatin bulk with DMF, CEP offered by Laurus Labs

    Find a price of Docetaxel bulk with CEP, WC offered by Laurus Labs

    Find a price of Lamivudine bulk with DMF, CEP offered by Laurus Labs

    Find a price of Lopinavir bulk with DMF, CEP offered by Laurus Labs

    Find a price of Oxaliplatin bulk with DMF, CEP offered by Laurus Labs

    Find a price of Pirfenidone bulk with DMF, CEP offered by Laurus Labs

    Find a price of Atazanavir Sulfate bulk with DMF, WC offered by Laurus Labs

    Find a price of Atorvastatin bulk with DMF, CEP offered by Laurus Labs

    Find a price of Azacitidine bulk with DMF, WC offered by Laurus Labs

    Find a price of Bictegravir Sodium bulk with DMF, WC offered by Laurus Labs

    Find a price of Cabazitaxel bulk with DMF, WC offered by Laurus Labs

    Find a price of Canagliflozin bulk with DMF, WC offered by Laurus Labs

    Find a price of Carfilzomib bulk with DMF, WC offered by Laurus Labs

    Find a price of Darunavir bulk with DMF, WC offered by Laurus Labs

    Find a price of Darunavir Ethanolate bulk with DMF, WC offered by Laurus Labs

    Find a price of Dolutegravir Sodium bulk with DMF, WC offered by Laurus Labs

    Find a price of Efavirenz bulk with DMF, WC offered by Laurus Labs

    Find a price of Emtricitabine bulk with DMF, WC offered by Laurus Labs

    Find a price of Enzalutamide bulk with DMF, WC offered by Laurus Labs

    Find a price of Erlotinib Hydrochloride bulk with DMF, WC offered by Laurus Labs

    Find a price of Fluocytosine bulk with DMF, WC offered by Laurus Labs

    Find a price of Imatinib Mesylate bulk with DMF, CEP offered by Laurus Labs

    Find a price of Levetiracetam bulk with CEP, WC offered by Laurus Labs

    Find a price of Pazopanib Hydrochloride bulk with DMF, WC offered by Laurus Labs

    Find a price of Pemetrexed Disodium bulk with DMF, WC offered by Laurus Labs

    Find a price of Rilpivirine Hydrochloride bulk with DMF, WC offered by Laurus Labs

    Find a price of Sitagliptin Phosphate bulk with DMF, CEP offered by Laurus Labs

    Find a price of Sofosbuvir bulk with DMF, WC offered by Laurus Labs

    Find a price of Tenofovir Alafenamide Fumarate bulk with DMF, WC offered by Laurus Labs

    Find a price of Thalidomide bulk with DMF, WC offered by Laurus Labs

    Find a price of Empagliflozin bulk with DMF offered by Laurus Labs

    Find a price of Gemcitabine bulk with JDMF offered by Laurus Labs

    Find a price of Macitentan bulk with DMF offered by Laurus Labs

    Find a price of Tenofovir Disoproxil Fumarate bulk with WC offered by Laurus Labs

    Find a price of Valsartan bulk with DMF offered by Laurus Labs

    Find a price of Abacavir bulk with WC offered by Laurus Labs

    Find a price of Abacavir Sulfate bulk with DMF offered by Laurus Labs

    Find a price of Apalutamide bulk with DMF offered by Laurus Labs

    Find a price of Atropine Sulfate bulk with WC offered by Laurus Labs

    Find a price of Brimonidine Tartrate bulk with WC offered by Laurus Labs

    Find a price of Capecitabine bulk with WC offered by Laurus Labs

    Find a price of Dabigatran Etexilate Mesylate bulk with WC offered by Laurus Labs

    Find a price of Daclatasvir bulk with WC offered by Laurus Labs

    Find a price of Docetaxel bulk with DMF offered by Laurus Labs

    Find a price of Dolutegravir Sodium bulk with DMF offered by Laurus Labs

    Find a price of Efavirenz bulk with DMF offered by Laurus Labs

    Find a price of Felbamate bulk with WC offered by Laurus Labs

    Find a price of Homatropine Methylbromide bulk with WC offered by Laurus Labs

    Find a price of Lenalidomide bulk with WC offered by Laurus Labs

    Find a price of Melatonin bulk with WC offered by Laurus Labs

    Find a price of Nevirapine bulk with WC offered by Laurus Labs

    Find a price of Oxaliplatin bulk offered by Laurus Labs

    Find a price of Raltegravir Potassium bulk with WC offered by Laurus Labs

    Find a price of Sacubitril Sodium bulk with WC offered by Laurus Labs

    Find a price of Sacubitril-Valsartan bulk with DMF offered by Laurus Labs

    Find a price of Sodium Zirconium Cyclosilicate bulk with DMF offered by Laurus Labs

    Find a price of Sunitinib bulk with WC offered by Laurus Labs

    Find a price of Temozolomide bulk with WC offered by Laurus Labs

    Find a price of Tenofovir Alafenamide Fumarate bulk with DMF offered by Laurus Labs

    Find a price of Tenofovir Disoproxil Fumarate bulk with DMF offered by Laurus Labs

    Find a price of Tenofovir Disoproxil Succinate bulk with WC offered by Laurus Labs

    Find a price of Velpatasvir bulk with WC offered by Laurus Labs

    Find a price of Vildagliptin bulk with JDMF offered by Laurus Labs

    Find a price of DOLUTEGRAVIR SODIUM (HXA) bulk with DMF offered by Laurus Labs

    Find a price of Bimatoprost bulk offered by Laurus Labs

    Find a price of Brimonidine Tartrate bulk offered by Laurus Labs

    Find a price of Carboplatin bulk offered by Laurus Labs

    Find a price of Cisplatin bulk offered by Laurus Labs

    Find a price of Clopidogrel bulk offered by Laurus Labs

    Find a price of Digoxin bulk offered by Laurus Labs

    Find a price of Esomeprazole Magnesium bulk offered by Laurus Labs

    Find a price of Etoricoxib bulk offered by Laurus Labs

    Find a price of Hydroxychloroquine Sulphate bulk offered by Laurus Labs

    Find a price of Latanoprost bulk offered by Laurus Labs

    Find a price of Lenalidomide bulk offered by Laurus Labs

    Find a price of Macitentan bulk offered by Laurus Labs

    Find a price of Metformin bulk offered by Laurus Labs

    Find a price of Montelukast Sodium bulk offered by Laurus Labs

    Find a price of Pemetrexed Disodium bulk offered by Laurus Labs

    Find a price of Ritonavir bulk offered by Laurus Labs

    Find a price of Sitagliptin Hydrochloride bulk offered by Laurus Labs

    Find a price of Sitagliptin Malate bulk offered by Laurus Labs

    Find a price of Abiraterone Acetate bulk offered by Laurus Labs

    Find a price of Atazanavir bulk offered by Laurus Labs

    Find a price of Bictegravir bulk offered by Laurus Labs

    Find a price of Camostat bulk offered by Laurus Labs

    Find a price of Cytosine bulk offered by Laurus Labs

    Find a price of Dapagliflozin bulk offered by Laurus Labs

    Find a price of Duloxetine Hydrochloride bulk offered by Laurus Labs

    Find a price of Elexacaftor bulk offered by Laurus Labs

    Find a price of Erlotinib bulk offered by Laurus Labs

    Find a price of Gabapentin bulk offered by Laurus Labs

    Find a price of Irbesartan bulk offered by Laurus Labs

    Find a price of Ivacaftor bulk offered by Laurus Labs

    Find a price of Levothyroxine Sodium bulk offered by Laurus Labs

    Find a price of Losartan Potassium bulk offered by Laurus Labs

    Find a price of Lufenuron bulk offered by Laurus Labs

    Find a price of Lumacaftor bulk offered by Laurus Labs

    Find a price of Miglustat bulk offered by Laurus Labs

    Find a price of Nilotinib bulk offered by Laurus Labs

    Find a price of Pemetrexed bulk offered by Laurus Labs

    Find a price of Posaconazole bulk offered by Laurus Labs

    Find a price of Ranolazine bulk offered by Laurus Labs

    Find a price of Rilpivirine bulk offered by Laurus Labs

    Find a price of Rosuvastatin bulk offered by Laurus Labs

    Find a price of Sildenafil Citrate bulk offered by Laurus Labs

    Find a price of Tenofovir bulk offered by Laurus Labs

    Find a price of Tezacaftor bulk offered by Laurus Labs

    Find a price of Venetoclax bulk offered by Laurus Labs

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search